Yu-waye Chu - Net Worth and Insider Trading
Yu-waye Chu Net Worth
The estimated net worth of Yu-waye Chu is at least $517,688 dollars as of 2024-06-07. Yu-waye Chu is the Chief Medical Officer of Fate Therapeutics Inc and owns about 140,676 shares of Fate Therapeutics Inc (FATE) stock worth over $517,688. Details can be seen in Yu-waye Chu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Yu-waye Chu has not made any transactions after 2023-04-18 and currently still holds the listed stock(s).
Transaction Summary of Yu-waye Chu
Yu-waye Chu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yu-waye Chu owns 2 companies in total, including Fate Therapeutics Inc (FATE) , and CytomX Therapeutics Inc (CTMX) .
Click here to see the complete history of Yu-waye Chu’s form 4 insider trades.
Insider Ownership Summary of Yu-waye Chu
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FATE | Fate Therapeutics Inc | 2023-04-18 | See Remarks |
| CTMX | CytomX Therapeutics Inc | 2023-07-19 | Chief Medical Officer |
Yu-waye Chu Latest Holdings Summary
Yu-waye Chu currently owns a total of 1 stock. Yu-waye Chu owns 140,676 shares of Fate Therapeutics Inc (FATE) as of April 18, 2023, with a value of $517,688.
Latest Holdings of Yu-waye Chu
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FATE | Fate Therapeutics Inc | 2023-04-18 | 140,676 | 3.68 | 517,688 |
Holding Weightings of Yu-waye Chu
Yu-waye Chu Form 4 Trading Tracker
According to the SEC Form 4 filings, Yu-waye Chu has made a total of 6 transactions in Fate Therapeutics Inc (FATE) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Fate Therapeutics Inc is the sale of 2,532 shares on April 18, 2023, which brought Yu-waye Chu around $16,635.
Insider Trading History of Yu-waye Chu
- 1
Yu-waye Chu Trading Performance
Yu-waye Chu Ownership Network
Yu-waye Chu Owned Company Details
What does Fate Therapeutics Inc do?
Who are the key executives at Fate Therapeutics Inc?
Yu-waye Chu is the See Remarks of Fate Therapeutics Inc. Other key executives at Fate Therapeutics Inc include Chief Financial Officer Dulac Edward J Iii , director & President and CEO J Scott Wolchko , and Chief Development Officer Bahram Valamehr .
Fate Therapeutics Inc (FATE) Insider Trades Summary
Over the past 18 months, Yu-waye Chu made 2 insider transaction in Fate Therapeutics Inc (FATE) with a net sale of 10,357. Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net sale of 26,108 shares made by Dulac Edward J Iii , a net purchase of 44,630 shares made by Redmile Group, Llc , and a net sale of 46,790 shares made by Cindy Tahl .
In summary, during the past 3 months, insiders sold 0 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 479,444 shares of Fate Therapeutics Inc (FATE) were sold and 471,648 shares were bought by its insiders, resulting in a net sale of 7,796 shares.
Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fate Therapeutics Inc Insider Transactions
Yu-waye Chu Mailing Address
Above is the net worth, insider trading, and ownership report for Yu-waye Chu. You might contact Yu-waye Chu via mailing address: Fate Therapeutics, Inc., 3535 General Atomics Court Ste 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
